Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : Covid-19 - U.S. Delivers 4m Doses Moderna Vaccines to Nigeria to Combat Pandemic - Embassy

08/03/2021 | 05:06am EDT

The U.S Mission to Nigeria has stated that the 4,000, 080 Moderna vaccines doses donated to Nigeria was part of President Joe Biden's commitment to combat the global COVID-19 pandemic.

Ms Kathleen FitzGibbon, Deputy Chief of Mission, US Embassy, said this at the official handover of the vaccines at the national briefing of the Presidential Steering Committee (PSC) on COVID-19 on Monday, in Abuja.

The News Agency Of Nigeria (NAN) reports that the 4,000,080 Moderna doses, which arrived on two flights on Sunday, at about 2:15 am of Aug 1, 2021, were received by UNICEF officials on behalf of Nigeria at the Nnamdi Azikiwe International Airport, Abuja.

The delivery was the second batch of vaccines to arrive Nigeria after four million doses were earlier delivered in March, under the COVAX vaccine sharing facility.

COVAX was set up to ensure the equitable distribution of vaccines, particularly to low-income countries, and has already delivered more than 80 million doses to 129 territories.

Nigeria has since exhausted the four million doses of the AstraZeneca vaccine received to kick-off her nationwide inoculation programme.

The Moderna vaccine received on Sunday is the mRNA type of vaccine manufactured and developed by Moderna NIAID. Two shots of the vaccine are administered through intramuscular injection, 28 days apart.

Listed for emergency use by the World Health Organisation (WHO) and approved by the National Agency for Food and Drug Administration and Control (NAFDAC), Modena vaccine is deemed safe and effective, based on data from large-scale clinical trials.

FitzGibbon disclosed that the United States, through COVAX and bilateral donations, was delivering millions of safe and effective COVID-19 vaccine doses to its partners, friends, and allies around the world.

She noted that the it worked with international partners to donate COVID-19 vaccines to the world to end the pandemic.

"America's support for the global fight against COVID-19 includes: donating 80 million vaccine doses from its supplies to other countries and purchasing 500 million vaccine doses to donate to nearly 100 developing countries.

"Contributing $2 billion to COVAX, the global initiative to equitably distribute safe and effective COVID-19 vaccines worldwide.

"Delivering essential medicines, supplies and therapeutics, as well as other assistance to help countries rebuild economies, overcome food shortages and strengthen health security.

"The United States will be the world's arsenal of vaccines in our shared fight against this virus, President Biden said in a June 3 statement.

"We will continue to do all we can to build a world that is safer and more secure against the threat of infectious disease", FitzGibbon explained.

She noted that in August, the 500 million doses of the Pfizer vaccine that President Biden committed just before the G7, would also start moving and a significant portion of those will be deployed to Africa.

NAN reports that the US government has begun the process of delivering 25 million doses, as quickly as possible, working closely with the African Union, governments, and COVAX.

Copyright Vanguard. Distributed by AllAfrica Global Media (allAfrica.com)., source News Service English

All news about MODERNA, INC.
09/19MODERNA : U.S. administers about 385.6 mln doses of COVID-19 vaccines -CDC
RE
09/19MODERNA : U.S. CDC Says Administered 385,586,012 Doses Of COVID-19 Vaccine As Of..
RE
09/19MODERNA : Key data on U.S. J&J, Moderna COVID-19 boosters weeks away, Fauci says
RE
09/19MODERNA : Key data on U.S. J&J, Moderna COVID-19 boosters 'weeks away,' Fauci sa..
RE
09/19MODERNA : "Waning immunity?" Experts say term leads to false understanding of CO..
AQ
09/18MODERNA : U.S. administers about 384.9 mln doses of COVID-19 vaccines -CDC
RE
09/18MODERNA : U.S. CDC Says Administered 384,911,290 Doses Of COVID-19 Vaccine As Of..
RE
09/17Wall Street ends rollercoaster week sharply lower
RE
09/17MODERNA : Torrid Moderna stock rally cools over booster shot doubts
RE
09/17Healthcare Shares Finish Up Slightly, Beating Broader Market -- Healthcare Ro..
DJ
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 20 348 M - -
Net income 2021 12 529 M - -
Net cash 2021 12 947 M - -
P/E ratio 2021 14,5x
Yield 2021 -
Capitalization 174 B 174 B -
EV / Sales 2021 7,89x
EV / Sales 2022 7,29x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 430,05 $
Average target price 306,23 $
Spread / Average Target -28,8%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.311.65%173 588
LONZA GROUP AG32.35%60 074
IQVIA HOLDINGS INC.43.07%49 116
CELLTRION, INC.-23.26%31 904
SEAGEN INC.-10.81%28 420
PHARMARON BEIJING CO., LTD.83.56%25 755